| Mar 30 2020 |
FTC Paid Endorser Settlement Sets Framework for Advertiser Best Practices |
Proskauer Rose LLP |
| Mar 30 2020 |
Defense Production Act: Presidential Directive to GM… What Does it Mean for Industry? |
Wiggin and Dana LLP |
| Mar 30 2020 |
FDA and USDA Temporarily Relax Nutrition Facts Labeling Requirement for Retail Distribution of Food by Restaurants and Food Manufacturers |
Keller and Heckman LLP |
| Mar 30 2020 |
DOT Issues Guidance on Drug and Alcohol Testing Regulations Amid COVID-19 Pandemic |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 29 2020 |
Whistleblower Suit Against Pharmaceutical Company Heads to Trial |
Katz Banks Kumin LLP |
| Mar 27 2020 |
FSIS Seeks to Expand Use of Term “Healthy” |
Keller and Heckman LLP |
| Mar 27 2020 |
Food Packaging Workers Listed as Essential by CISA |
Keller and Heckman LLP |
| Mar 27 2020 |
Boards of Pharmacy Nationwide Respond to COVID-19 Pandemic |
Mintz |
| Mar 27 2020 |
Old Fashioned to Go? Alcohol Beverages May Be Ordered on a Carry-Out Basis During the COVID-19 Pandemic |
Davis|Kuelthau, s.c. |
| Mar 27 2020 |
China's Food Laws: Looking Back on 2019, the Year of the Pig |
Keller and Heckman LLP |
| Mar 27 2020 |
EPA Announces Continued Efforts to Help Increase Availability of Disinfectant Products for Use Against COVID-19 |
Bergeson & Campbell, P.C. |
| Mar 27 2020 |
US EPA Issues Temporary Policy on COVID-19 Implications for the Agency’s Enforcement and Compliance Assurance Program |
Squire Patton Boggs (US) LLP |
| Mar 26 2020 |
Massachusetts Issues COVID-19 Orders and Related Guidance for Pharmacies and Pharmacy Professionals |
Robinson & Cole LLP |
| Mar 26 2020 |
Marijuana Regulatory Agency Expediting Licenses for Home Delivery During COVID-19 Crisis |
Varnum LLP |
| Mar 26 2020 |
Physicians Committee for Responsible Medicine Files Lawsuit Against the State of California Alleging OEHHA Failed to Include Processed Meat on Prop 65 List |
Keller and Heckman LLP |
| Mar 26 2020 |
COVID-19: FDA Issues Guidance for Ventilator and Respirator Manufacturers |
Foley & Lardner LLP |
| Mar 26 2020 |
Crisis & Compliance: EU Competition Law During COVID-19 |
McDermott Will & Schulte LLP |
| Mar 26 2020 |
Legal Implications Of COVID-19 For Pharmaceutical And Medical Device Companies In France |
McDermott Will & Schulte LLP |
| Mar 25 2020 |
Top 10 Questions Asked By Medical Group Clients In Response To COVID-19 |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 25 2020 |
Legal Implications of COVID-19 for Pharmaceutical and Medical Device Companies in the United Kingdom |
McDermott Will & Schulte LLP |
| Mar 25 2020 |
Stated Purpose More Decisive than Definition in Construing Claims |
McDermott Will & Schulte LLP |
| Mar 25 2020 |
US EPA Revises TSCA Chemical Data Reporting Requirements and Extends Deadline for 2020 Reporting Period |
Squire Patton Boggs (US) LLP |
| Mar 25 2020 |
COVID-19 Vaccine Test Lab Hit by Maze Ransomware |
Robinson & Cole LLP |
| Mar 25 2020 |
DEA Releases Draft Rules Related to Cannabis Medical Research |
Dinsmore & Shohl LLP |
| Mar 25 2020 |
False Advertisement and Unjust Enrichment Claims Against Kombucha Brewer Dismissed for Lack of Notice and Lack of Conferred Benefit |
Keller and Heckman LLP |
| Mar 25 2020 |
USDA Extends Comment Period for Salmonella Citizen Petition |
Keller and Heckman LLP |
| Mar 25 2020 |
Five Things Brand Owners Should Do Now To Guard Against Increase in Scams and Counterfeit Goods During COVID-19 Pandemic |
Dinsmore & Shohl LLP |
| Mar 25 2020 |
Florida Issues New Emergency Order Further Relaxing Licensure, Telehealth, and Practice Standards to Combat COVID-19 |
Foley & Lardner LLP |
| Mar 25 2020 |
Rhode Island Issues Emergency Regulations on Off-Label Prescribing for COVID-19, and Guidance on Telehealth and Reciprocal Licensure |
Robinson & Cole LLP |
| Mar 25 2020 |
FDA Seeks to Improve Ventilator Access, Relaxes REMS Requirements During COVID-19 |
McDermott Will & Schulte LLP |
| Mar 25 2020 |
Cannabusinesses Should Take Advantage of Their Extra Time to File Tax Returns to Ensure Proper Reductions in Their Taxable Income for Cost of Goods Sold |
Norris McLaughlin P.A. |
| Mar 24 2020 |
New OIG and FBI Announcements Highlight Coronavirus Fraud Schemes Targeting Americans |
Jones Walker LLP |
| Mar 24 2020 |
COVID-19 and the New Jersey Alcoholic Beverage Industry |
Norris McLaughlin P.A. |
| Mar 24 2020 |
Medical Marijuana Deemed “Essential” During COVID-19 Pandemic |
Epstein Becker & Green, P.C. |
| Mar 24 2020 |
Enforcers, Experts Discuss Tamping Down Anticompetitive Behavior in Bio Market During FDA/FTC Workshop |
MoginRubin |
